Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone + Citalopram for Negative Symptoms in Schizophrenia
NCT00893256Phase 4Completed
- Sponsor
- National Institute of Mental Health and Neurosciences
- Start
- Dec 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of citalopram in schizophrenia, sponsored by National Institute of Mental Health and Neurosciences. Started Dec 2004; status: completed.
02
Drugs
citalopram
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00893256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00893256.